TrialCytotherapy2014

Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial.

Amish N Raval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.